FindTrial
Sign In

Analysis of cause of death and mortality according to the non-invasive intrahepatic fibrosis evaluation index in general population, 2006-2021

Analysis of cause of death and mortality according to the non-invasive intrahepatic fibrosis evaluation index in general population, 2006-2021

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008849
Enrollment
90000
Registered
2023-10-06
Start date
2023-05-02
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Seoul Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 2003-2007 Health Checkup Subjects For Koreans aged 19-70

Exclusion criteria

Exclusion criteria: Excluding chronic hepatitis B and C Excessive alcohol liver disease excluded (average of the past year, male 210g (3 bottles of soju), female 140g (2 bottles of soju) per week) Excluding previous liver cancer, other carcinomas, and cardio diseases Organ transplantation / Excluding deaths other than diseases (traffic accidents) If even one value such as AST, ALT, Platelet, Age, BMI (height, weight), IFG/Diabetes, Albumin, Globulin is missing

Design outcomes

Primary

MeasureTime frame
- The total mortality, liver disease-related mortality, and cardiovascular disease-related death for each indicator of SAFE, FIB-4, NFS, and APRI were checked, and whether there was a statistically significant difference was checked.—

Secondary

MeasureTime frame
- Confirmation of the statistically superior index in mortality by cause.—

Countries

Korea, Republic of

Contacts

Public ContactDae Won Jun

Hanyang University

gongori1004@gmail.com+82-2-2290-8334

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026